Mar. 7, 2026
BioMarin Outlines Strategy Refresh, Voxzogo Competition, and 40% Margin Goal
Executives detail pipeline updates, financial targets, and plans for acquisitions at healthcare conference
Mar. 6, 2026
BridgeBio Pharma Outlines Clinical Wins, Commercial Momentum, and Tafamidis IP Trial
CEO Neil Kumar discusses the company's recent progress, upcoming regulatory plans, and market opportunities during a healthcare conference.
Mar. 5, 2026
Providence in Talks to Sell Napa's Queen of the Valley Medical Center to NorthBay Health
The potential sale comes as hospitals nationwide face financial pressures from Medicaid reimbursement cuts and other business trends.
Mar. 5, 2026
Alnylam and Tenaya Partner in Potential $1B+ Deal to Develop Heart Disease Treatments
The alliance aims to identify new genetic targets for cardiovascular disease therapies.
Mar. 5, 2026
Alnylam, Tenaya Announce $1.1B Cardiovascular Drug Pact
Tenaya Therapeutics stock jumps on research collaboration with Alnylam Pharmaceuticals.
Mar. 4, 2026
Tandem Diabetes Care Announces Record Margins, New Tubeless Pump, and Pharmacy Shift
Company highlights strong Q4 performance, international expansion, and major reimbursement changes in the U.S.
Mar. 4, 2026
Zacks Research Boosts Omnicell Q1 Earnings Forecast
Analysts raise estimates for the healthcare technology company's upcoming quarterly results.
Mar. 3, 2026
Advantmed Appoints New Chief Medical Officer
Dr. Matt Lambert to lead product strategy for healthcare tech company
Mar. 3, 2026
Heron Therapeutics Reports Strong Q4 and Full-Year 2025 Results
Company plans to accelerate commercial investments in 2026 to drive sustained revenue growth and free cash flow generation.
Mar. 2, 2026
Care@Home 4 Life Appoints Industry Veteran Daniel Peters as Regional Sales Director
Peters brings over 15 years of senior care and financial expertise to advance Care@Home 4 Life's mission of keeping seniors safely in their homes.
Feb. 27, 2026
Ashly Alyas Drives Global Brand Strategy at ZEISS Medical Technology
Marketing Manager Leverages Data-Driven Insights to Enhance Visibility and Impact in Ophthalmology Division
Feb. 27, 2026
Carlsmed Leads Competitors in Personalized Spine Surgery Solutions
Carlsmed's AI-enabled aprevo Technology Platform aims to optimize patient outcomes and reduce revision surgeries.
Feb. 27, 2026
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Tividenofusp alfa (DNL310; ETV:IDS) launch readiness established ahead of April 5, 2026 PDUFA target action date for Hunter syndrome
Feb. 27, 2026
Amphastar Pharmaceuticals Reports Q4 Earnings
Highlights include new FDA approvals, BAQSIMI growth, and expectations for mid-to-high single-digit revenue growth in 2026.
Feb. 26, 2026
SteinCares and Shilpa Biologicals Strike Licensing Deal for Biosimilars in Latin America
Partnership aims to expand patient access to cost-effective treatments across the region
Feb. 25, 2026
Anbio Biotechnology Outperforms Oncocyte in Head-to-Head Review
Anbio Biotechnology's higher revenue and earnings give it an edge over Oncocyte, according to industry analysts.
Feb. 24, 2026
Prime Healthcare Services Schedules 4th Quarter 2025 Earnings Call
The healthcare provider will report Q4 2025 results on March 17, 2026 and host a conference call the same day.
Feb. 24, 2026
Edwards Lifesciences to Present at Healthcare Conferences
Medical device company's CFO to speak at Barclays and Leerink Partners events.
Feb. 24, 2026
Gilead Sciences to Present at Upcoming Investor Conferences
Biopharmaceutical company to share updates at major healthcare industry events.
Feb. 23, 2026
Robinson Pharma Sponsors Santa Ana's Annual Tết Lunar New Year Festival
Leading nutraceutical manufacturer supports community celebration of Vietnamese and Asian culture.
